Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/28/2012CN102793779A Liver benefiting polysaccharide tablet
11/28/2012CN102793761A Windflower extract, preparation method and application thereof
11/28/2012CN102793757A Yellow lead anti-cancer tablet
11/28/2012CN102793748A Magnolia zenii seed extract and application thereof
11/28/2012CN102793729A Triptolide and chinese brake herb general flavone combined medicinal composition and preparation and application thereof
11/28/2012CN102793724A Diamondback moth extract and application thereof
11/28/2012CN102793722A Application of human mesenchymal stem cells in preparing medicament for treating M3 leukemia
11/28/2012CN102793702A Therapeutic agent for liver cancer
11/28/2012CN102793689A 2-methoxyestradiol dry powder inhalant serving as antitumor medicament and preparation method thereof
11/28/2012CN102793678A Method for preparing tween-free docetaxel injection
11/28/2012CN102793677A Method for preparing gemcitabine hydrochloride lyophilized powder
11/28/2012CN102793676A Sesquiterpene lactone (1 beta, 10 beta-epoxy-13-alpha-dimethylamino-1,2-propanediol 3-(4)-alkene-6,12-lactone) dimethylamine hydrochloride freeze-drying preparation for injection and preparation method for sesquiterpene lactone (1 beta, 10 beta-epoxy-13-alpha-dimethylamino-1,2-propanediol 3-(4)-alkene-6,12-lactone) dimethylamine hydrochloride freeze-drying preparation
11/28/2012CN102793671A Human recombinant epidermal growth factor (hrEGF)-modified cisplatin-loaded polymeric nanoparticles and preparation method and application thereof
11/28/2012CN102793667A Plutella xylostella antimicrobial peptide liposome, as well as preparation method and application thereof
11/28/2012CN102793666A Liposome for anthocyanin extract and preparation method for liposome
11/28/2012CN102793665A Flexible nanoliposomes with procyanidine and preparation method for flexible nanoliposomes
11/28/2012CN102793664A Sodium aescinate micro-emulsification injection and preparation method thereof
11/28/2012CN102793663A Sustained-release microsphere injection containing antitumor drug (2-methoxyestradiol)
11/28/2012CN102793032A Health-preserving fungal tea and application thereof
11/28/2012CN102343099B Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs
11/28/2012CN102302719B Medicament for treating tumor
11/28/2012CN102302649B Traditional Chinese medicine composition for treating hysteromyoma
11/28/2012CN102283973B Traditional Chinese medicine plaster for treating benign tumor and reducing weight and preparation method thereof
11/28/2012CN102266297B Miriplatin freeze-dried powder injection and preparation method thereof
11/28/2012CN102228433B Supersaturated self-microemulsion as well as preparation method and application thereof
11/28/2012CN102210702B Calf spleen extract for treating tumors
11/28/2012CN102153644B Antigenic peptide for dimerization of epidermal growth factor receptor
11/28/2012CN102125589B Preparation method and use of active ingredients of red ginseng
11/28/2012CN102125521B Paclitaxel emulsion, preparation method and application thereof
11/28/2012CN102094020B RNA (Ribose Nucleic Acid) interference sequence and recombined interference plasmid for inhibiting fucosyltransferase I synthesized by LeY carbohydrate antigens
11/28/2012CN102094019B RNA (Ribose Nucleic Acid) interference sequence and recombined interference plasmid for inhibiting fucosyltransferase IV synthesized by LeY carbohydrate antigens
11/28/2012CN102085361B Application of medicament containing hirudin and hementerin
11/28/2012CN102002048B Water-soluble anionic bacteriochlorophyll derivatives and their uses
11/28/2012CN101993446B Novel benzanthracene cyclic compounds and preparation method and use thereof
11/28/2012CN101899039B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/28/2012CN101862456B Remedy
11/28/2012CN101812292B Method for preparing protein ribonuclease modified zinc telluride quantum dot
11/28/2012CN101744837B Preparation method for sinonovacula constricta enzymolysis liquid with diversified bioactivities
11/28/2012CN101717397B Substituted pyridino-[2',1':2,3] imidazo[4,5-c] isoquinolone compounds, method for synthesizing same, use of same and medicinal composition having same
11/28/2012CN101696183B (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
11/28/2012CN101684119B 5,8-disubstituted-1,6-quinazoline-7-amidocarbonylation compound, preparing method, composite and application thereof
11/28/2012CN101617827B Supramolecular composite of isosteviol or derivative thereof and preparation method thereof
11/28/2012CN101602791B Integrin receptor target lipidosome drug carrier, preparation method and application thereof
11/28/2012CN101574386B Application of active ingredients of thunder god vine for regulating heat shock protein and retinol X receptor Alpha
11/28/2012CN101549048B Effective component of vervain and preparation method thereof
11/28/2012CN101538315B Method for preparing Leuprorelin by combination of solid phase method and liquid phase method
11/28/2012CN101535264B Pyridinone compounds
11/28/2012CN101469004B Platinum complexes
11/28/2012CN101386644B Pumpkin protein 2 and preparation method and application thereof
11/28/2012CN101384275B Dissolution aids for oral peptide delivery comprising a biguanide
11/28/2012CN101331134B Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/28/2012CN101258130B Isoquinolines as igf-1r inhibitors
11/28/2012CN101072588B Liposomes with improved drug retention for treatment of cancer
11/27/2012US8318931 Chemokine receptor antagonists and use thereof
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318815 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
11/27/2012US8318796 Heterocyclic compounds and thrombopoietin receptor activators
11/27/2012US8318790 Heat Shock Protein 90 (HSP90); treating cancer, inflammatory disorders, angiogenesis inhibition, infections; 3-substituted-4-fused(hetero)aryl-5-phenyl-4H-1,2,4-triazoles
11/27/2012US8318764 Macrocyclic inhibitors of JAK
11/27/2012US8318753 (-)-5-(3-Chlorophenyl)- alpha -(4-chlorophenyl)- alpha -(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts; anticancer agent
11/27/2012US8318752 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318740 Compounds for protein kinase inhibition
11/27/2012US8318731 Pyrrolopyrimidines
11/27/2012US8318696 Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative
11/27/2012US8318691 Treatment of tumors with genetically engineered herpes virus
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318683 Anti-cancer therapies
11/27/2012US8318640 Methods for selective targeting
11/27/2012US8318186 Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
11/27/2012US8318177 Viral chemokine-antigen fusion proteins
11/27/2012US8318174 Survivin-derived peptides and use thereof
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012CA2706571C 5-anilinoimidazopyridines and methods of use
11/27/2012CA2658221C Anti-cd40 monoclonal antibody
11/27/2012CA2653664C Phosphine transition metal complex, process for producing same, and anticancer agent
11/27/2012CA2643400C Camptothecin derivatives and their uses
11/27/2012CA2634169C Method for treating disseminated cancer
11/27/2012CA2611778C Compositions and methods for the diagnosis and treatment of tumor
11/27/2012CA2597300C Novel betulinic acid derivatives
11/27/2012CA2594802C Ibandronate polymorph a
11/27/2012CA2577745C Hcv inhibiting bi-cyclic pyrimidines
11/27/2012CA2569016C Fused heterocyclic compound
11/27/2012CA2542663C Microemulsions of retinoids, and pharmaceutical compositions containing them
11/27/2012CA2531505C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
11/27/2012CA2525214C Macrocyclic quinazoline derivatives as antiproliferative agents
11/27/2012CA2516702C Modified t cell receptor linked by disulphide bond between constant domain cysteine residues
11/27/2012CA2515790C Heterocyclic kinase inhibitors
11/27/2012CA2481390C Nanoparticulate megestrol formulations
11/27/2012CA2451051C Siglec inhibitors
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/22/2012WO2012159122A1 Heparin-based compositions and methods for the inhibition of metastasis
11/22/2012WO2012158994A1 4-amino-5-fluoro-3- [6- (4 -methylpiperazin- 1 - yl) - 1h - benzimidazol - 2 - yl] - 1h - quinoli n-2-one for use in the treatment of adenoid cystic carcinoma
11/22/2012WO2012158979A1 Quinazoline-7-ether compounds and methods of use
11/22/2012WO2012158810A1 Tyrosine kinase inhibitors
11/22/2012WO2012158795A1 Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
11/22/2012WO2012158789A2 Methods and compositions for inhibiting neddylation of proteins
11/22/2012WO2012158764A1 Tyrosine kinase inhibitors
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 2211